JP2017508144A5 - - Google Patents

Download PDF

Info

Publication number
JP2017508144A5
JP2017508144A5 JP2016551166A JP2016551166A JP2017508144A5 JP 2017508144 A5 JP2017508144 A5 JP 2017508144A5 JP 2016551166 A JP2016551166 A JP 2016551166A JP 2016551166 A JP2016551166 A JP 2016551166A JP 2017508144 A5 JP2017508144 A5 JP 2017508144A5
Authority
JP
Japan
Prior art keywords
sortilin
kit according
bipolar disorder
subject
subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016551166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017508144A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/052506 external-priority patent/WO2015121166A1/en
Publication of JP2017508144A publication Critical patent/JP2017508144A/ja
Publication of JP2017508144A5 publication Critical patent/JP2017508144A5/ja
Pending legal-status Critical Current

Links

JP2016551166A 2014-02-12 2015-02-06 感情／気分障害のバイオマーカーとしてのソルチリンの使用 Pending JP2017508144A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201400075 2014-02-12
DKPA201400075 2014-02-12
PCT/EP2015/052506 WO2015121166A1 (en) 2014-02-12 2015-02-06 Use of sortilin as biomarker for affective/mood disorders

Publications (2)

Publication Number Publication Date
JP2017508144A JP2017508144A (ja) 2017-03-23
JP2017508144A5 true JP2017508144A5 (enExample) 2018-03-22

Family

ID=52462923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016551166A Pending JP2017508144A (ja) 2014-02-12 2015-02-06 感情／気分障害のバイオマーカーとしてのソルチリンの使用

Country Status (6)

Country Link
US (1) US20160349276A1 (enExample)
EP (1) EP3105594A1 (enExample)
JP (1) JP2017508144A (enExample)
CN (1) CN105980858A (enExample)
HK (1) HK1232289A1 (enExample)
WO (1) WO2015121166A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10849992B1 (en) 2015-04-07 2020-12-01 Alector Llc Methods of screening for sortilin binding antagonists
HUE057432T2 (hu) 2015-04-07 2022-05-28 Alector Llc Anti-sortilin antitestek és ezek alkalmazási módjai
FR3057267A1 (fr) * 2016-10-11 2018-04-13 Centre National De La Recherche Scientifique - Cnrs - Procede de diagnostic/determination de l'efficacite de traitement de la depression
US11622948B2 (en) 2017-11-09 2023-04-11 The Trustees Of Columbia University In The City Of New York Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
WO2019094757A1 (en) 2017-11-09 2019-05-16 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders in females
RS64034B1 (sr) 2018-07-13 2023-04-28 Alector Llc Anti-sortilin antitela i načini njihove upotrebe
CN111351945B (zh) * 2020-03-18 2021-04-23 东南大学 维生素d结合蛋白作为标志物在精神疾病抑郁症诊断中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010069331A2 (en) * 2008-12-19 2010-06-24 H. Lundbeck A/S Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
GB0903417D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Ltd Biomarkers
GB0922240D0 (en) * 2009-12-21 2010-02-03 Cambridge Entpr Ltd Biomarkers
GB201021502D0 (en) * 2010-12-20 2011-02-02 Cambridge Entpr Ltd Biomarkers

Similar Documents

Publication Publication Date Title
JP2017508144A5 (enExample)
Kagiyama et al. Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis
Tanizawa et al. The prognostic value of HRCT in myositis-associated interstitial lung disease
Bahadır et al. Applications of electrochemical immunosensors for early clinical diagnostics
JP6364488B2 (ja) 認知欠損を治療するための個別化医療的手法
Aw et al. Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender
HK1258292A1 (zh) 使用il23途徑生物標誌物預測il23拮抗劑的臨床應答
Goldberg et al. Predictive value of familiality, stressful life events and gender on the course of obsessive-compulsive disorder
WO2020055954A3 (en) Methods for detecting liver diseases
Addissouky Detecting liver fibrosis by recent reliable biomarkers in viral hepatitis patients
JP2013503617A5 (enExample)
MX2018007589A (es) Ccl20 como indicador de respuesta clinica a antagonistas de il23.
JP2018004657A5 (enExample)
Bellan et al. Association between red cell distribution width and response to methotrexate in rheumatoid arthritis
Ligon et al. Biomarkers in scleroderma: progressing from association to clinical utility
JP2017524933A5 (enExample)
Lee et al. Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia
JP2011196840A (ja) 急性大動脈解離の検査方法
JP7497851B2 (ja) アルツハイマー病診断のためのアッセイ
Petramala et al. Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism
Branford Monitoring and defining early response: where to draw the line?
JP2015503106A5 (enExample)
SG10201709117RA (en) In Vitro Diagnostic Method For Alzheimer's Disease Based On The Albumin Redox Level In The Cerebrospinal Fluid
Huang et al. Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnoea
PL422387A1 (pl) Sposób oznaczania wrażliwości tkanek na insulinę, sposób identyfikacji insulinooporności i/lub określania predyspozycji do zaburzenia z nią związanego, zastosowanie wskaźnika insulinowrażliwości oraz zestawy diagnostyczne i ich zastosowania